Investors seeking to bet against Tesla's (TSLA) common stock may want to give its convertible bonds a spin, said Edward Silverstein, portfolio manager for the MainStay Convertible fund (MCOAX) . Silverstein is long Tesla's 1.25% convertibles, now trading around $0.84 on the dollar and yielding 4.7%, due in March 2021 and short equal amount of the automaker's common stock, which was trading around $200 at last check. Silverstein is also bullish on Oasis Petroleum (OAS) converts, saying the driller has a cost advantage. Oasis recently issued a convertible security 2.625% due September 2023. Silverstein is also constructive on Intercept Pharmaceuticals' (ICPT) recently issued convertible security yielding 3.25% and due 2023. The company recently won approval for Oclavia, a treatment for liver disease and is trying to get approval for treatment for another liver indication that has a much larger treatment population.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.